Market Tracker

08/28 6:01pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

178.86
Delayed Data
As of Aug 28
 -0.96 / -0.53%
Today’s Change
150.06
Today|||52-Week Range
208.88
-3.33%
Year-to-Date

Today’s Trading

Previous close179.82
Today’s open178.40
Day’s range176.32 - 180.00
Volume1,477,803
Average volume (3 months)1,835,052
Market cap$40.5B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-6.28%
Earnings growth (next 5 years)+21.83%
Revenue growth (last year)+46.49%
P/E ratio61.1
Price/Sales16.84
Price/Book10.78

Competitors

 Today’s
change
Today’s
% change
SHPGShire+3.00+1.29%
VRTXVertex Pharmaceutica...+0.30+0.22%
PRGOPerrigo Company PLC-2.77-1.47%
MYLMylan NV-1.12-2.18%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.03
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts